bucladesine and 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine

bucladesine has been researched along with 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho-Chung, YS; Eisenbrand, G; Habermeyer, M; Hippe, F; Jakobs, S; Marko, D; Wagner, B1

Other Studies

1 other study(ies) available for bucladesine and 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine

ArticleYear
7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells.
    Biochemical pharmacology, 2002, Feb-15, Volume: 63, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Bucladesine; Consensus Sequence; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; DNA; Humans; Isoenzymes; Nuclear Proteins; Phosphodiesterase Inhibitors; Piperazines; Pteridines; Tumor Cells, Cultured

2002